ARCHIVES

Piperacillin/Tazobactam Valuable Empiric Therapy For Febrile Neutropenia

This article is from The Cancer Letter archive.

Vol. 26 No. 10 | October 31, 2003

Download PDF Visit The Full Archive

Related Articles

Cancer Prevention: Review Group’s Report Urges Integration Of Prevention with all NCI Research

June 27, 1997

DCPC Advisors Begin Process Of Setting Priorities For Research

June 21, 1991

ACS Plans 7 Hearings Around U.S. On cancer In The Disadvantaged

April 7, 1989

Radiation, Tamoxifen After Surgery Reduce Breast Cancer Occurrence

March 25, 2011

DCT Board Sends Letter Opposing Bill Requiring Research On RU 486

November 13, 1992

In Brief: Breakthrough Prize Awarded to 11 Scientists

March 8, 2013